Johnson & Johnson’s share price has had a 70% winning trade ratio over the last 20 years. Johnson & Johnson is a healthcare stock that was founded in 1886. The company develops consumer packaged goods and medical devices alongside pharmaceutical products. If the US is heading towards a recession health stocks have historically proven fairly resilient during recessions as medical care is still prioritised even as consumers cut back on other products.
From April 7 to May 15 Johnson & Johnson has gained 14 times in the last 20 years. The average return has been +2.43% with a 25.84% annualised growth rate.
Will Johnson & Johnson gain again this year in the period outlined?
Trade Risks: The main risk to this trade is any very negative news for Johnson & Johnson and/or a very hard US recession which could weigh on US stocks more generally.
HYCM clients can access the Seasonax product in order to analyse over 25,000 currency pairs, indices, commodities, as well as individual stocks. Please contact your account manager for a free trial. Certain products & services mentioned herein may or may not be available to all clients depending on which HYCM Capital Markets Group entity their trading account(s) adheres to.